Source: Journal of clinical oncology. Unidade: FM
Subjects: MICOSES (DIAGNÓSTICO), FUNGOS, LINFOMA (TERAPIA), MANIFESTAÇÕES CUTÂNEAS, PROGNÓSTICO, BIÓPSIA, LINFEDEMA (ETIOLOGIA), HEMORRAGIA (ETIOLOGIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLSEN, Elise A et al. Clinical end points and response criteria in mycosis fungoides and sézary syndrome: A consensus statement of the international society for cutaneous lymphomas, the United States cutaneous lymphoma consortium, and the cutaneous lymphoma task force of the European Organisation for Research and Treatment of Cancer. Journal of clinical oncology, v. 29, n. 18, p. 2598-2607, 2011Tradução . . Disponível em: https://doi.org/10.1200/JCO.2010.32.0630. Acesso em: 28 set. 2024.APA
Olsen, E. A., Whittaker, S., Kim, Y. H., Duvic, M., Prince, H. M., Lessin, S. R., et al. (2011). Clinical end points and response criteria in mycosis fungoides and sézary syndrome: A consensus statement of the international society for cutaneous lymphomas, the United States cutaneous lymphoma consortium, and the cutaneous lymphoma task force of the European Organisation for Research and Treatment of Cancer. Journal of clinical oncology, 29( 18), 2598-2607. doi:10.1200/JCO.2010.32.0630NLM
Olsen EA, Whittaker S, Kim YH, Duvic M, Prince HM, Lessin SR, Wood GS, Willemze R, Demierre M-F, Pimpinelli N, Bernengo MG, Ortiz-Romero PL, Bagot M, Estrach T, Guitart J, Knobler R, Sanches Júnior JA, Iwatsuki K, Sugaya M, Dummer R, Pittelkow M, Hoppe R, Parker S, Geskin L, Pinter-Brown L, Girardi M, Burg G, Ranki A, Vermeer M, Horwitz S, Heald P, Rosen S, Cerroni L, Dreno B, Vonderheid EC. Clinical end points and response criteria in mycosis fungoides and sézary syndrome: A consensus statement of the international society for cutaneous lymphomas, the United States cutaneous lymphoma consortium, and the cutaneous lymphoma task force of the European Organisation for Research and Treatment of Cancer [Internet]. Journal of clinical oncology. 2011 ; 29( 18): 2598-2607.[citado 2024 set. 28 ] Available from: https://doi.org/10.1200/JCO.2010.32.0630Vancouver
Olsen EA, Whittaker S, Kim YH, Duvic M, Prince HM, Lessin SR, Wood GS, Willemze R, Demierre M-F, Pimpinelli N, Bernengo MG, Ortiz-Romero PL, Bagot M, Estrach T, Guitart J, Knobler R, Sanches Júnior JA, Iwatsuki K, Sugaya M, Dummer R, Pittelkow M, Hoppe R, Parker S, Geskin L, Pinter-Brown L, Girardi M, Burg G, Ranki A, Vermeer M, Horwitz S, Heald P, Rosen S, Cerroni L, Dreno B, Vonderheid EC. Clinical end points and response criteria in mycosis fungoides and sézary syndrome: A consensus statement of the international society for cutaneous lymphomas, the United States cutaneous lymphoma consortium, and the cutaneous lymphoma task force of the European Organisation for Research and Treatment of Cancer [Internet]. Journal of clinical oncology. 2011 ; 29( 18): 2598-2607.[citado 2024 set. 28 ] Available from: https://doi.org/10.1200/JCO.2010.32.0630